Latest News & Features
Americas
Pfizer has sued Breckenridge Pharmaceutical, Pensa Pharma and Laboratorios del Dr Esteve for patent infringement of its drug Xeljanz. 24 March 2017
Americas
The US Chamber of Commerce has urged the Canadian government to address its ‘promise utility doctrine’, claiming that it “dramatically undermines legal certainty for medical innovators in Canada”. 23 March 2017
Americas
A Biogen patent covering the drug Tecfidera has been upheld by the Patent Trial and Appeal Board, after a challenge from Kyle Bass’s Coalition for Affordable Drugs. 23 March 2017
Big Pharma
The English High Court has ruled that a supplementary protection certificate owned by Merck Sharp & Dohme is invalid because it didn’t comply with European regulations. 23 March 2017
Americas
Sanofi and Regeneron have filed a declaratory judgment of non-infringement claiming that their product Dupixent does not infringe a patent belonging to Amgen. 22 March 2017
Americas
Fluorescent reagent company Biotium has filed a complaint against biotech company Genecopoeia for patent and trademark infringement, as well as unfair competition. 21 March 2017
Americas
The Canadian government has won nearly $5 million in an arbitration claim filed by Eli Lilly which alleged wrongful termination of its drug patents. 21 March 2017
Big Pharma
There have been two significant references on issues that have been "left hanging" by the Court of Justice of the European Union in the last spate of decisions, says Paul England, senior associate at Taylor Wessing, in a video interview with LSIPR. 21 March 2017
Americas
Dow Agrosciences has secured attorneys’ fees from Bayer in a patent dispute, after Bayer failed in its appeal to the US Court of Appeals for the Federal Circuit. 20 March 2017
Americas
Allergan Pharmaceuticals and genome-editing company Editas Medicine have entered into a strategic research and development agreement over CRISPR technology. 20 March 2017